[Chinese expert consensus on management of dyslipidemia in the elderly]

M L Liu1, Z F Zhang1, P Fu1

  • 1Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.

Zhonghua Nei Ke Za Zhi
|October 8, 2022
PubMed

Insights

This expert consensus addresses dyslipidemia management in Chinese elderly, focusing on safe lipid-lowering drug use to prevent atherosclerotic cardiovascular disease (ASCVD) and reduce cardiovascular events.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Dyslipidemia is a key risk factor for atherosclerotic cardiovascular disease (ASCVD).
  • Statins are effective in preventing ASCVD events but are underutilized in the elderly due to safety concerns.
  • High withdrawal rates of lipid-lowering agents are observed in older populations.

Purpose of the Study:

  • To provide guidance on managing dyslipidemia in Chinese elderly patients.
  • To promote the effective and safe use of lipid-lowering drugs in this demographic.
  • To address the challenges of insufficient drug use and high withdrawal rates.

Main Methods:

  • Review of clinical evidence on lipid-lowering drug use in the elderly.
  • Analysis of domestic and international lipid management guidelines.
  • Consensus development by experts in geriatrics and cardiology.

Main Results:

  • Identification of specific challenges in lipid management for Chinese elderly.
  • Recommendations for optimizing statin therapy and other lipid-lowering agents.
  • Strategies to improve adherence and reduce drug withdrawal.

Conclusions:

  • Effective management of dyslipidemia is crucial for preventing ASCVD in Chinese elderly.
  • This consensus provides evidence-based recommendations for safe and effective lipid-lowering therapy.
  • Addressing safety concerns and adherence is vital for improving cardiovascular outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
23
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
937
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
812
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
269